Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Image result for mental health aging research
open11 viewsUSA

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

A funding opportunity from the National Institutes of Health for research on schizophrenia and related disorders in mid- to late-life. Supports R21 clinical trials with case-dependent funding.

Who can apply

Applicants must follow the Research (R) Instructions in the How to Apply - Application Guide. The opportunity is open to those proposing high risk/high reward projects that lack preliminary data.